These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 24593051

  • 1. Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
    Wang C, Dai J, Yang M, Deng G, Xu S, Jia Y, Boden G, Ma ZA, Yang G, Li L.
    FEBS J; 2014 May; 281(9):2136-47. PubMed ID: 24593051
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic nesfatin-1/NUCB2 knockdown augments hepatic gluconeogenesis that is correlated with inhibition of mTOR-STAT3 signaling pathway in rats.
    Wu D, Yang M, Chen Y, Jia Y, Ma ZA, Boden G, Li L, Yang G.
    Diabetes; 2014 Apr; 63(4):1234-47. PubMed ID: 24478398
    [Abstract] [Full Text] [Related]

  • 3. STAT3 targets the regulatory regions of gluconeogenic genes in vivo.
    Ramadoss P, Unger-Smith NE, Lam FS, Hollenberg AN.
    Mol Endocrinol; 2009 Jun; 23(6):827-37. PubMed ID: 19264844
    [Abstract] [Full Text] [Related]

  • 4. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
    Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, Iida M, Kobayashi T, Yoshimura A.
    Oncogene; 2006 Apr 20; 25(17):2520-30. PubMed ID: 16474852
    [Abstract] [Full Text] [Related]

  • 5. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
    Wu C, Khan SA, Peng LJ, Li H, Carmella SG, Lange AJ.
    Am J Physiol Endocrinol Metab; 2006 Sep 20; 291(3):E536-43. PubMed ID: 16621898
    [Abstract] [Full Text] [Related]

  • 6. Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs.
    Xu P, Zhang Y, Jiang X, Li J, Song L, Khoso MH, Liu Y, Wu Q, Ren G, Li D.
    PLoS One; 2016 Sep 20; 11(5):e0155598. PubMed ID: 27203422
    [Abstract] [Full Text] [Related]

  • 7. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.
    Kim YD, Kim YH, Cho YM, Kim DK, Ahn SW, Lee JM, Chanda D, Shong M, Lee CH, Choi HS.
    Diabetologia; 2012 May 20; 55(5):1482-94. PubMed ID: 22349108
    [Abstract] [Full Text] [Related]

  • 8. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
    Kanatani Y, Usui I, Ishizuka K, Bukhari A, Fujisaka S, Urakaze M, Haruta T, Kishimoto T, Naka T, Kobayashi M.
    Diabetes; 2007 Mar 20; 56(3):795-803. PubMed ID: 17327450
    [Abstract] [Full Text] [Related]

  • 9. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
    Xia N, Tang Z, Wang C, Xu G, Nie X, Zhang W, Zhao Y, Wang S, Zhu X, Cui S.
    Biochem Biophys Res Commun; 2007 Mar 20; 463(1-2):116-22. PubMed ID: 26002461
    [Abstract] [Full Text] [Related]

  • 10. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
    Sachithanandan N, Fam BC, Fynch S, Dzamko N, Watt MJ, Wormald S, Honeyman J, Galic S, Proietto J, Andrikopoulos S, Hevener AL, Kay TW, Steinberg GR.
    Hepatology; 2010 Nov 20; 52(5):1632-42. PubMed ID: 20799351
    [Abstract] [Full Text] [Related]

  • 11. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.
    Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, Teshigawara K, Matsuki Y, Watanabe E, Hiramatsu R, Notohara K, Katayose K, Okamura H, Kahn CR, Noda T, Takeda K, Akira S, Inui A, Kasuga M.
    Cell Metab; 2006 Apr 20; 3(4):267-75. PubMed ID: 16581004
    [Abstract] [Full Text] [Related]

  • 12. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
    Ishizuka K, Usui I, Kanatani Y, Bukhari A, He J, Fujisaka S, Yamazaki Y, Suzuki H, Hiratani K, Ishiki M, Iwata M, Urakaze M, Haruta T, Kobayashi M.
    Endocrinology; 2007 Jun 20; 148(6):2994-3003. PubMed ID: 17379643
    [Abstract] [Full Text] [Related]

  • 13. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.
    Braunschweig A, Poehlmann TG, Busch S, Schleussner E, Markert UR.
    Am J Reprod Immunol; 2011 Oct 20; 66(4):329-35. PubMed ID: 21385272
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
    Dimitriadis E, Stoikos C, Tan YL, Salamonsen LA.
    Endocrinology; 2006 Aug 20; 147(8):3809-17. PubMed ID: 16709613
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.
    Jiang C, Kim JH, Li F, Qu A, Gavrilova O, Shah YM, Gonzalez FJ.
    J Biol Chem; 2013 Feb 08; 288(6):3844-57. PubMed ID: 23255598
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The dual function of hepatic SOCS3 in insulin resistance in vivo.
    Torisu T, Sato N, Yoshiga D, Kobayashi T, Yoshioka T, Mori H, Iida M, Yoshimura A.
    Genes Cells; 2007 Feb 08; 12(2):143-54. PubMed ID: 17295835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.